Business Of Biotech cover image

Building A Biotech Hub with Intellia Therapeutics' John Leonard, M.D.

Business Of Biotech

CHAPTER

Clinical Pipeline Update and Future Plans

This chapter provides an update on the company's clinical pipeline, including phase three progress of Loydosis for TTRM and plans for hereditary angioedema program. They also discuss plans for expanding technologies to other areas and mention future plans for ophthalmological diseases and allogeneic ex vivo work.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner